Pdt Partners, LLC Evogene Ltd. Transaction History

Pdt Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.63 - $2.83 $126,161 - $219,042	-77,400 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.45 - $3.45 $217,601 - $306,418	-88,817 Reduced 53.43%	77,400 $204,000
Q2 2021 Aug 16, 2021	SELL	$3.3 - $5.02 $63,673 - $96,860	-19,295 Reduced 10.4%	166,217 $568,000
Q1 2021 May 17, 2021	BUY	$4.29 - $9.94 $444,109 - $1.03 Million	103,522 Added 126.26%	185,512 $935,000
Q4 2020 Feb 16, 2021	BUY	$2.41 - $5.63 $197,595 - $461,603	81,990 New	81,990 $385,000

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $61.4M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.